Product information and disease descriptionPlace of product in therapyApproaches to treatment
Current treatment options and standard of care
85 evidence topics · 48 sources
Metastatic castration-resistant prostate cancer previously treated with abiraterone, in combination with darolutamide
Product information and disease descriptionPlace of product in therapyApproaches to treatment
85 evidence topics · 48 sources